Grants and Contributions:
Title:
Bioavailability enhancement using new and existing polymers, providing new ways to deliver selected insoluble small and peptide molecules.
Agreement Number:
908413
Agreement Value:
$344,500.00
Agreement Date:
Jun 1, 2018 - Nov 22, 2019
Description:
The objective of the project is to find new polymer platforms to deliver existing drugs, and along with existing polymers developed by the company, verify the value of their drug delivering platforms - allowing insoluble small and peptides molecules to be administered in new ways.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mirabel, Quebec, CA J7J 1P3
Reference Number:
172-2018-2019-Q2-908413
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
803976687
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 56 days.
Amendment Date
Aug 9, 2019
Recipient's Legal Name:
Altus Formulation Inc.
Federal Riding Name:
Mirabel
Federal Riding Number:
24048
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32541
Amendments: